# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-23-024277
Filing Date
2023-07-12
Accepted
2023-07-11 18:35:04
Documents
28
Period of Report
2023-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 48942
2 |  | ex4-1.htm | EX-4.1 | 111623
3 |  | ex4-2.htm | EX-4.2 | 9423
4 |  | ex10-1.htm | EX-10.1 | 79200
5 |  | ex10-2.htm | EX-10.2 | 12306
6 |  | ex10-2_001.jpg | GRAPHIC | 4389
10 |  | ex4-2_001.jpg | GRAPHIC | 403423
11 |  | ex4-2_002.jpg | GRAPHIC | 340118
12 |  | ex4-2_003.jpg | GRAPHIC | 456410
13 |  | ex4-2_004.jpg | GRAPHIC | 493417
14 |  | ex4-2_005.jpg | GRAPHIC | 404387
15 |  | ex4-2_006.jpg | GRAPHIC | 416954
16 |  | ex4-2_007.jpg | GRAPHIC | 380880
17 |  | ex4-2_008.jpg | GRAPHIC | 77172
18 |  | ex4-2_0090.jpg | GRAPHIC | 42190
19 |  | ex4-2_010.jpg | GRAPHIC | 99972
20 |  | ex4-2_011.jpg | GRAPHIC | 51863
| Complete submission text file | 0001493152-23-024277.txt |  | 4847802

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | ppcb-20230629.xsd | EX-101.SCH | 3012
8 | XBRL LABEL FILE | ppcb-20230629_lab.xml | EX-101.LAB | 34240
9 | XBRL PRESENTATION FILE | ppcb-20230629_pre.xml | EX-101.PRE | 22357
22 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3109

Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 231082960
SIC: 2834 Pharmaceutical Preparations